Coherus Oncology Inc. (CHRS)
NASDAQ: CHRSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
CHRS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $156.05M
- EPS (TTM)
- -$1.25
- Dividend yield
- None
- 52-week range
- 1.01 – 2.62
- Day range
- 1.01 – 1.08
- Volume / Avg
- 1.23M / 1.14M
- Beta
- —
- Shares outstanding
- 154.50M
- Next earnings
- Nov 5, 2026
52-week range
CHRS stock today
Shares of Coherus Oncology (CHRS) finished lower on Oct 7 at $1.01, a drop of 1.94% or $0.02 per share, versus the S&P 500's 0.22% decline. At this level, CHRS sits near the bottom of its 52-week range of $1.01 to $2.62: 61.4% below the high, set on Jan 27, 2026 and 0.0% above the low. CHRS is down 28.9% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 40.9%.
Coherus Oncology has posted a net loss over the last twelve months (EPS of -$1.25), so its P/E ratio is not meaningful. Coherus Oncology's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Coherus Oncology
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2014
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.22
Coherus Oncology peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CRDLCardiol Therapeutics Inc. Class A | 1.32 | +0.76% | $160.40M | vs CHRS |
| TARAProtara Therapeutics Inc. | 2.59 | +1.37% | $153.06M | vs CHRS |
| VYGRVoyager Therapeutics Inc. | 2.47 | +0.41% | $152.20M | vs CHRS |
| ABOSAcumen Pharmaceuticals Inc. | 2.10 | +3.45% | $151.87M | vs CHRS |
| IPHAInnate Pharma S.A. ADS | 1.52 | -4.40% | $169.78M | vs CHRS |
| MOLNMolecular Partners AG ADR | 3.81 | +0.79% | $145.94M | vs CHRS |
| DTILPrecision BioSciences Inc. | 6.25 | +0.81% | $172.51M | vs CHRS |
| OTLKOutlook Therapeutics Inc. | 0.59 | +3.15% | $143.63M | vs CHRS |
Indexes, lists and sector
Coherus Oncology stock FAQ
What is Coherus Oncology's stock price today?
CHRS last traded at $1.01 as of Oct 7, 4:00 PM EDT, down 1.94% on the day. Prices are delayed at least 15 minutes.
When is Coherus Oncology's next earnings date?
Coherus Oncology is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.22.
What is the CHRS 52-week high?
The 52-week high for CHRS is $2.62 and the 52-week low is $1.01. The stock is currently 61.4% below its high.